Combination of antigen pulsed APCS and interleukin 12 for tumor and viral therapy

Details for Australian Patent Application No. 2004200444 (hide)

Owner Arch Development Corporation Genetics Institute, LLC.

Inventors Fallarino, Francesca; Gajewski, Thomas F

Agent Griffith Hack

Pub. Number AU-A-2004200444

Parent 767208

Filing date 6 February 2004

Wipo publication date 4 March 2004

International Classifications

A61K 039/00 Medicinal preparations containing antigens or antibodies

Event Publications

26 February 2004 Complete Application Filed

4 March 2004 Application Open to Public Inspection

  Published as AU-A-2004200444

2 September 2004 Amendment Made

  The nature of the amendment is: Amend the invention title to read Vaccine adjuvants for immunotherapy of melanoma

17 November 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004200445-Compositions having improved stability

2004200443-Dimer-selective RXR modulators and methods for their use